Table 1 Demographic characteristics of exploration study participants
Controls | FES | P-valuea | |
|---|---|---|---|
Participants, n | 17 | 17 | 1 |
Male | 8 | 8 | |
Female | 9 | 9 | |
Age (years), mean (SD) | 24.9 (1.2) | 23.5 (6.7) | 0.49 |
DOI (weeks), mean (SD) | NA | 39.3 (50.4) | NA |
DUP (weeks), mean (SD) | NA | 31.7 (52.1) | NA |
GAF, mean (SD) | NA | 37.5 (10.2) | NA |
PANSS positive, mean (SD) | NA | 15.1 (4.8) | NA |
PANSS negative, mean (SD) | NA | 18.6 (8.9) | NA |
PANSS general psychopathology, mean (SD) | NA | 34.4 (10.4) | NA |
Chlorpromazine dose (mg/day), mean (SD) | NA | 469.1 (513.8) | NA |
